Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Minocycline for Reducing Symptom Burden in Colorectal Cancer
NCT01906008Phase 2Completed
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Nov 2013
- Primary completion
- Feb 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of minocycline in chemotherapy-induced peripheral neuropathy (CIPN), sponsored by University of Texas MD Anderson Cancer Center. Started Nov 2013; status: completed.
02
Drugs
minocycline
03
Conditions
chemotherapy-induced peripheral neuropathy (CIPN)
Beyond the preview
Go deeper on NCT01906008.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01906008.